Login / Signup

Intravitreal faricimab as an adjuvant in the management of tubercular uveitis.

Yasmine AlcibahyKarina JulianM Fernanda BonillaAli MohamedSarah AmraniAniruddha Kishandutt Agarwal
Published in: Retinal cases & brief reports (2023)
Intravitreal faricimab, given its angiopoietin-2 (ang2) inhibition and anti-vascular endothelial growth factor action, maybe a helpful adjunct in IOTB. Whether ang2 inhibition provides any additional benefit needs further evaluation in extensive studies.
Keyphrases